Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ф. Хоффманн-Ля Рош АгfiledCriticalФ. Хоффманн-Ля Рош Аг
Publication of UA96460C2publicationCriticalpatent/UA96460C2/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
There is provided a film coated pharmaceutical composition comprising capecitabine and at least one disintegrant to form a rapidly disintegrating tablet. This tablet disintegrates in water at 37 °C in a USP Disintegration Apparatus in less than 2 minutes and have a hardness of 8-13 strong Cobb-Units.
Use of an IL-18 inhibitor for the manufacture of a medicament for the treatment or prevention of liver injury and other diseases, the use of a vector and a cell in the manufacture of an inhibitor, and a pharmaceutical composition comprising an IL-18 inhibitor.
ORAL PHARMACEUTICAL COMPOSITION INCLUDING LEVODOPA IN A UNIT DOSE OF AROUND 100 TO AROUND 500 MG AND AN ADEQUATE EXCIPIENT; AND ITS USE TO TREAT PARKINSON.